Abiopharma

News list

Fortress Biotech, Inc. 🟢 acquired 111.2K shares of AVENUE THERAPEUTICS, INC. (ATXI) Transaction Date: Jan 02, 2026 | Filing ID: 000004

Full text

News bot Jan. 6, 2026, 9:18 p.m.
🔍 Fortress Biotech, Inc. (Executive)

Company: AVENUE THERAPEUTICS, INC. (ATXI)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 111,209
Detailed Transactions and Holdings:
- Acquired 111,209 shares of COMMON STOCK, PAR VALUE $0.0001 (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 439,733.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The Reporting Person is entitled to an annual dividend on its Class A Preferred Stock equal to 2.5% of the Issuer's fully diluted outstanding capitalization on December 31. 111,209 shares were granted by the Issuer to the reporting Person for the 2025 annual dividend.